Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
https://www.axios.com/2026/03/17/strait-hormuz-iran-blockade-oil-trump-coalition...
https://www.axios.com/local/salt-lake-city/2026/03/17/kouri-richins-convicted-aggravated-murder...
